Cargando…

Comparative in vitro analysis of inhibition of rhinovirus and influenza virus replication by mucoactive secretolytic agents and plant extracts

BACKGROUND: Rhinoviruses and influenza viruses cause millions of acute respiratory infections annually. Symptoms of mild acute respiratory infections are commonly treated with over-the-counter products like ambroxol, bromhexine, and N-acetyl cysteine, as well as of thyme and pelargonium extracts tod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walther, Christin, Döring, Kristin, Schmidtke, Michaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757078/ https://www.ncbi.nlm.nih.gov/pubmed/33357221 http://dx.doi.org/10.1186/s12906-020-03173-2

Ejemplares similares

Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?
por: Scaglione, Francesco, et al.
Publicado: (2019)

Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists
por: Volpi, Sonia, et al.
Publicado: (2022)

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
por: Charrier, Cedric, et al.
Publicado: (2014)

A reappraisal of the mucoactive activity and clinical efficacy of bromhexine
por: Zanasi, Alessandro, et al.
Publicado: (2017)

Mucoactive agents for acute respiratory failure in the critically ill: a systematic review and meta-analysis
por: Anand, Rohan, et al.
Publicado: (2020)

Early administration of mucoactive agents and ventilator-free days: a propensity score-matched study
por: Fujinaga, Jun, et al.
Publicado: (2023)

Mucoactive agent use in adult UK Critical Care Units: a survey of health care professionals’ perception, pharmacists’ description of practice, and point prevalence of mucoactive use in invasively mechanically ventilated patients
por: Borthwick, Mark, et al.
Publicado: (2020)

Rational use of mucoactive medications to treat pediatric airway disease
por: Linssen, R.S.N., et al.
Publicado: (2020)

Fungal Deoxynivalenol-Induced Enterocyte Distress Is Attenuated by Adulterated Adlay: In Vitro Evidences for Mucoactive Counteraction
por: Du, Zhimin, et al.
Publicado: (2018)

Quercetin inhibits rhinovirus replication in vitro and in vivo
por: Ganesan, Shyamala, et al.
Publicado: (2012)

Evaluation of pharmacodynamic activities of EPs(®) 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis
por: Bao, Yanyan, et al.
Publicado: (2015)

Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians
por: Yan, Xixin, et al.
Publicado: (2017)

(1)H NMR-Based Biochemometric Analysis of Morus alba Extracts toward a Multipotent Herbal Anti-Infective
por: Langeder, Julia, et al.
Publicado: (2022)

Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection
por: Dissanayake, Thrimendra Kaushika, et al.
Publicado: (2020)

Corrigendum: Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection
por: Dissanayake, Thrimendra Kaushika, et al.
Publicado: (2020)

Human rhinovirus promotes STING trafficking to replication organelles to promote viral replication
por: Triantafilou, Martha, et al.
Publicado: (2022)

Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract
por: Essaidi-Laziosi, Manel, et al.
Publicado: (2022)

Rhinoviruses as critical agents in severe bronchiolitis in infants
por: Bastos, Juliana Cristina Santiago, et al.
Publicado: (2021)

Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data
por: Granger, Emily, et al.
Publicado: (2023)

Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication
por: Guedán, Anabel, et al.
Publicado: (2017)

Cryptoporus volvatus Extract Inhibits Influenza Virus Replication In Vitro and In Vivo
por: Gao, Li, et al.
Publicado: (2014)

Effects of β (2) Agonists, Corticosteroids, and Novel Therapies on Rhinovirus-Induced Cytokine Release and Rhinovirus Replication in Primary Airway Fibroblasts
por: Van Ly, David, et al.
Publicado: (2011)

Rhinovirus C replication is associated with the endoplasmic reticulum and triggers cytopathic effects in an in vitro model of human airway epithelium
por: Gagliardi, Talita B., et al.
Publicado: (2022)

Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses
por: Bochkov, Yury A, et al.
Publicado: (2013)

Effects of Vitamin D on Airway Epithelial Cell Morphology and Rhinovirus Replication
por: Brockman-Schneider, Rebecca A., et al.
Publicado: (2014)

Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations
por: Akoto, C., et al.
Publicado: (2017)

Pomegranate peel extract inhibits internalization and replication of the influenza virus: An in vitro study
por: Moradi, Mohammad-Taghi, et al.
Publicado: (2020)

Efficacy of Influenza Vaccination and Tamiflu® Treatment – Comparative Studies with Eurasian Swine Influenza Viruses in Pigs
por: Duerrwald, Ralf, et al.
Publicado: (2013)

Human rhinoviruses and enteroviruses in influenza-like illness in Latin America
por: Garcia, Josefina, et al.
Publicado: (2013)

Rhinoviruses.
por: Gwaltney, J. M.
Publicado: (1975)

Rhinoviruses
por: Falsey, Ann R., et al.
Publicado: (2017)

Rhinoviruses
por: Mackay, Ian M., et al.
Publicado: (2014)

Rhinoviruses
por: Winther, B.
Publicado: (2008)

Rhinovirus replication and innate immunity in highly differentiated human airway epithelial cells
por: Warner, Stephanie M., et al.
Publicado: (2019)

Fragmentation of the Golgi apparatus provides replication membranes for human rhinovirus 1A
por: Quiner, Claire A., et al.
Publicado: (2010)

A systems approach to understanding human rhinovirus and influenza virus infection
por: Kim, Taek-Kyun, et al.
Publicado: (2015)

Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention
por: Hayden, Frederick G.
Publicado: (2000)

Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication
por: Vanderwall, Elizabeth R., et al.
Publicado: (2022)

Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae
por: Grienke, Ulrike, et al.
Publicado: (2016)

Rhinovirus chemotherapy
por: Patick, Amy K.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_bjvb63k7i125hemlqv5va7so28